Clinical activity of crizotinib in lung adenocarcinoma harboring a HLA_A-ROS1 rearrangement: A case report

被引：0
作者：
Kinoshita, Ryosuke [1 ]
Nakao, Makoto [1 ,2 ]
Kiyotoshi, Hiroko [1 ]
Hayashi, Syuntaro [1 ]
Sugihara, Masahiro [1 ]
Hirata, Yuya [1 ]
Kuriyama, Mamiko [1 ]
Takeda, Norihisa [1 ]
Muramatsu, Hideki [1 ]
机构：
[1] Kainan Hosp Aichi Prefectural Welf Federat Agr Coo, Dept Resp Med, Yatomi, Aichi 4988502, Japan
[2] Kainan Hosp Aichi Prefectural Welf Federat Agr Coo, Dept Resp Med, 396 Minamihonndenn,Maegasu Cho, Yatomi, Aichi 4988502, Japan
来源：
ONCOLOGY LETTERS | 2023年 / 26卷 / 06期
关键词：
crizotinib; HLA_A-ROS1; Lung adenocarcinoma; multigene panel assay;
D O I：
10.3892/ol.2023.14102
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The benefits of crizotinib therapy in patients with tyrosine receptor kinase ROS proto-oncogene 1 (ROS1)-rearranged non-small cell lung cancer (NSCLC) have been demonstrated. The present study reports a 47-year-old woman with lung adenocarcinoma harboring a rare HLA_A-ROS1 rearrangement with clinical response to crizotinib. To the best of our knowledge there have been no reports of HLA_A-ROS1-rearranged lung cancer regarding clinical course and the efficacy of treatment with crizotinib. A good response to crizotinib therapy in the present case could be a reference for the treatment and prognosis of ROS1-rearranged NSCLC with the same fusion partner. The current report will remind oncologists and pulmonologists to consider the importance of accurate multigene panel assays for detecting driver oncogenes in treating patients with NSCLC.
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Acquired MET D1228N Mutations Mediate Crizotinib Resistance in Lung Adenocarcinoma with ROS1 Fusion: A Case Report
    Wang, Yu
    Chen, Zheng
    Han, Xiao
    Li, Jiamei
    Guo, Honglin
    Shi, Junping
    ONCOLOGIST, 2021, 26 (03) : 178 - 181
  • [32] Identification of a novel WNK1-ROS1 fusion in a lung adenocarcinoma sensitive to crizotinib
    Liu, Yutao
    Liu, Tianfeng
    Li, Nan
    Wang, Tao
    Pu, Yue
    Lin, Rui
    LUNG CANCER, 2019, 129 : 92 - 94
  • [33] Surgical resection of lung adenocarcinoma after crizotinib treatment: report of a case
    Kaoru Kaseda
    Ken-ichi Watanabe
    Keisuke Asakura
    Akio Kazama
    World Journal of Surgical Oncology, 13
  • [34] Surgical resection of lung adenocarcinoma after crizotinib treatment: report of a case
    Kaseda, Kaoru
    Watanabe, Ken-ichi
    Asakura, Keisuke
    Kazama, Akio
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13
  • [35] Crizotinib Efficacy After Progression With Entrectinib in ROS1-Positive Lung Cancer: A Case Report
    Taban, Hakan
    Guven, Deniz Can
    Kilickap, Saadettin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [36] THE FREQUENCY AND IMPACT OF ROS1-REARRANGEMENT ON CLINICAL OUTCOMES IN NEVER-SMOKERS WITH LUNG ADENOCARCINOMA
    Kim, Hye Ryun
    Lim, Sun Min
    Shim, Hyo Sup
    Ou, Sai-Hong I.
    Haack, Herbert
    Kim, Hyun Jung
    Jewell, Susan
    Wang, Jun
    Kim, Joo Hang
    Cho, Byoung Chul
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S297 - S298
  • [37] Miliary lung metastases from ROS1-rearranged lung adenocarcinoma: A case report
    Otoshi, Ryota
    Sekine, Akimasa
    Okudela, Koji
    Katano, Takuma
    Asaoka, Masato
    Ikeda, Satoshi
    Baba, Tomohisa
    Komatsu, Shigeru
    Hagiwara, Eri
    Ogura, Takashi
    MOLECULAR AND CLINICAL ONCOLOGY, 2020, 13 (01) : 80 - 82
  • [38] Intestinal metastasis from primary ROS1 -positive lung adenocarcinoma cancer patients responding to crizotinib
    Chen, Hua-fei
    Zhang, Qu-xia
    Zhu, You-cai
    Du, Kai-qi
    Li, Xiao-feng
    Wu, Li-xin
    Wang, Wen-xian
    Xu, Chun-wei
    ONCOTARGETS AND THERAPY, 2018, 11 : 7821 - 7825
  • [39] Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma
    Ota, Takayo
    Masuda, Noriyuki
    Matsui, Kaoru
    Yamada, Takao
    Tanaka, Noriko
    Fujimoto, Shunsuke
    Fukuoka, Masahiro
    INTERNAL MEDICINE, 2019, 58 (18) : 2651 - 2655
  • [40] An elderly female patient with ROS1 rearrangement primary lung adenocarcinoma and breast carcinoma: a rare case report and review of the literature
    Yang, Xiaojuan
    Qin, Diyuan
    Zhang, Yu
    Li, Xue
    Liu, Ning
    Zhou, Ying
    Feng, Ming
    Wang, Yongsheng
    PRECISION CLINICAL MEDICINE, 2019, 2 (03) : 197 - 203
12345